Determination of absorbed dose of organs (thyroid, sternum, cervical vertebra) in thyroid cancer patients following radioiodine therapy
Authors
Abstract:
Introduction: In patients with thyroid carcinoma, radiation absorbed doses of the thyroid and surrounding tissues is important to weigh risk and benefit considerations. In nuclear medicine, the accuracy of absorbed dose of internally distributed radionuclides is estimated by different methods such as MIRD and direct method using TLD. The aim of this study is using TLD and a phantom to determine the amount of cumulated activity in thyroid and surrounding tissues. Methods: Thermoluminescent dosimeter (TLD) measurements were performed on 27 patients on the skin over the thyroid, sternum and cervical vertebra. There were 5 TLDs for each organ which they were taken after 4, 8, 12, 20 and 24 hr. To calculate the amount of activity in the thyroid a head and neck phantom with a source of 10 mCi of 131I was used. Several TLDs were placed putted on the surface of thyroid on phantom (similar to patients) for 24 hr and then compared the dose of phantom and patients followed by calculation of the activity in patient's thyroid. Results: TLD measurements showed cumulated radiation absorbed doses (cGy) of 315.6, 348.1 and 361.9 for thyroid with administration of 100, 150 and 175 mCiof 131I, respectively. For sternum the values found to be 201.5 cGy, 275.2 cGy and 242.6 cGy. For cervical vertebra results were 311.5 cGy, 184.1 cGy and 325.9 cGy. The average of measurements was 33.3 cGy using of TLDs on phantom and absorbed activity in thyroid were 94.9, 104.6 and 108.8 mCi in 24 hr for mentioned doses administration. Conclusion: In this work a method to obtain the absorbed activity in the thyroid and other surrounding tissues is described. By this method, the amount of 131I needed for each patient also could be determined. The results of this work can be used in estimation of absorbed dose in thyroid and other organs using of MIRD method.
similar resources
determination of absorbed dose of organs (thyroid, sternum, cervical vertebra) in thyroid cancer patients following radioiodine therapy
introduction: in patients with thyroid carcinoma, radiation absorbed doses of the thyroid and surrounding tissues is important to weigh risk and benefit considerations. in nuclear medicine, the accuracy of absorbed dose of internally distributed radionuclides is estimated by different methods such as mird and direct method using tld. the aim of this study is using tld and a phantom to determine...
full textDetermination of Absorbed Dose of Organs (Thyroid, Sternum, Cervical vertebra) in Thyroid Cancer Patients Following Radioiodine Therapy
Introduction: In patients with thyroid carcinoma, radiation absorbed doses of the thyroid and surrounding tissues is important to weigh risk and benefit considerations. In nuclear medicine, the accuracy of absorbed dose of internally distributed radionuclides is estimated by different methods such as MIRD and direct method using TLD. The aim of this study is using TLD and a phantom to determine...
full textChanges in salivary gland function following radioiodine therapy of thyroid diseases: A comparison of high-dose therapy for thyroid cancer and low-dose therapy for benign thyroid disease
Introduction: High-dose radioactive iodine therapy in differentiated thyroid cancer (DTC) may adversely affect the salivary gland function. This study is aimed to evaluate the effect of radioactive iodine (RAI) with dose of 100 mCi in DTC patients compared to lower doses of less than 30 mCi in hyperthyroid cases. Methods: Fifty four patients (13 men and 41 women) age: 42.3±14.3 (21-71) years w...
full textchanges in salivary gland function following radioiodine therapy of thyroid diseases: a comparison of high-dose therapy for thyroid cancer and low-dose therapy for benign thyroid disease
introduction: high-dose radioactive iodine therapy in differentiated thyroid cancer (dtc) may adversely affect the salivary gland function. this study is aimed to evaluate the effect of radioactive iodine (rai) with dose of 100 mci in dtc patients compared to lower doses of less than 30 mci in hyperthyroid cases. methods: fifty four patients (13 men and 41 women) age: 42.3±14.3 (21-71) years w...
full textDetermination of organ doses in radioiodine therapy using medical internal radiation dosimetry (MIRD) method
Background: Radioiodine therapy has proven to be an effective method in the treatment of patients with differentiated thyroid carcinoma after thyroidectomy. The scope of this study is to describe a method to obtain the dose of organs using medical internal radiation dosimetry (MIRD) method. At the end, the results of MIRD calculations were compared with thermoluminescent dosimeter (TLD...
full textChanges in salivary gland function following radioiodine therapy of thyroid diseases: A comparison of high-dose therapy for thyroid cancer and low-dose therapy for benign thyroid disease
Introduction: High-dose radioactive iodine therapy in differentiated thyroid cancer (DTC) may adversely affect the salivary gland function. This study is aimed to evaluate the effect of radioactive iodine (RAI) with dose of 100 mCi in DTC patients compared to lower doses of less than 30 mCi in hyperthyroid cases. Methods: Fifty four patients (13 men and 41 women) age: 42.3±14.3 (21-71) years we...
full textMy Resources
Journal title
volume 17 issue 1
pages 27- 33
publication date 2009-05-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023